11 – 20 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Plasma insulin-like growth factor binding protein 1 in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Longitudinal changes in risk status in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension : call for a refined assessment
(
- Contribution to journal › Article
-
Mark
Multiple manifestations of systemic sclerosis affect walk distance
(
- Contribution to journal › Letter
- 2020
-
Mark
Poor outcome of patients with pulmonary arterial hypertension with insufficient response to phosphodiesterase-5 inhibitors alone or in combination with other specific therapy : a registry-based study
(
- Contribution to journal › Article
-
Mark
Mycophenolate mofetil for systemic sclerosis : Drug exposure exhibits considerable inter-individual variation-a prospective, observational study
(
- Contribution to journal › Article
- 2019
-
Mark
Patientens perspektiv på att leva med PAH eller CTEPH i Sverige : Enkätstudie visar på betydelsen av adekvat och upprepad information
(
- Contribution to journal › Article
-
Mark
Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se
(
- Contribution to journal › Article
-
Mark
Health-related quality of life, treatment adherence and psychosocial support in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
(
- Contribution to journal › Article
-
Mark
Everyday life experiences of spouses of patients who suffer from pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
(
- Contribution to journal › Article